US 9963450
A3 adenosine receptor agonists
granted A61PA61P29/00A61P35/00
Quick answer
US patent 9963450 (A3 adenosine receptor agonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P29/00, A61P35/00